The STEP trial program, which included thousands of participants, demonstrated average body weight reductions of 15 to 17 percent over 68 weeks
In comparison, subcutaneously administered semaglutide given as a single injection (0.5 mg) has shown a C max of 10 nM with T max of 24 h with a similar 1-week half life [30]
Although patients receiving exenatide IR and experiencing longer durations of nausea and vomiting tended to lose more weight, those in the trial group who did not experience the gastrointestinal symptoms (70%) generally lost weight as well (166, 224)
If you have diabetes and take insulin or sulfonylureas alongside your GLP-1 medicine, check your blood glucose levels during headaches to rule out hypoglycaemia
Keeping track of your readings helps you notice patterns early and act before things get worse
It also slows down the digestive process and the speed at which food moves through the stomach, leading to a decreased appetite